日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

[Non-invasive assessment of liver fibrosis: prioritizing dynamic monitoring and expanding population screening]

[肝纤维化的无创评估:优先考虑动态监测和扩大人群筛查]

Lai, P P; Chen, S Y; Sun, Y M; You, H

[Predictive role of dynamic changes in liver stiffness measurement for liver-related endpoint events in chronic hepatitis B]

[肝脏硬度测量动态变化对慢性乙型肝炎肝脏相关终点事件的预测作用]

Sun, C L; Chen, S Y; Wu, X N; Zhou, J L; Meng, T T; Wang, B Q; Zhao, X Y; Ou, X J; Jia, J D; Sun, Y M; You, H

[Distribution characteristics of serum HBsAg levels in Chinese patients with chronic hepatitis B based on CR-HepB]

[基于CR-HepB的中国慢性乙型肝炎患者血清HBsAg水平分布特征]

Chen, S Y; Shan, S; Kong, Y Y; Xu, X Q; Wang, H; Wu, X N; Zhou, J L; Wang, B Q; Meng, T T; Zhang, M Y; Jia, J D; Sun, Y M; You, H

Blood Cathepsins on the Risk of Alzheimer's Disease and Related Pathological Biomarkers: Results from Observational Cohort and Mendelian Randomization Study

血液组织蛋白酶与阿尔茨海默病风险及相关病理生物标志物的关系:来自观察性队列研究和孟德尔随机化研究的结果

Qian, X-H; Ding, G-Y; Chen, S-Y; Liu, X-L; Zhang, M; Tang, H-D

[Comparison of the population covered by the 2024 version of the WHO's hepatitis B prevention and treatment guidelines and the Chinese antiviral treatment guidelines]

【世界卫生组织2024年版乙型肝炎防治指南与中国抗病毒治疗指南覆盖人群的比较】

Wang, B Q; Shan, S; Kong, Y Y; Wu, X N; Zhou, J L; Sun, Y M; Chen, S Y; Wang, H; Xu, X Q; Xia, S; Jia, J D; You, H

[Efficiency and safety analysis of Plerixafor combined with granulocyte colony-stimulating factor on autologous hematopoietic stem cell mobilization in lymphoma]

[普乐沙福联合粒细胞集落刺激因子对淋巴瘤自体造血干细胞动员的疗效和安全性分析]

Ji, M M; Shen, Y G; Gong, J C; Tang, W; Xu, X Q; Zheng, Z; Chen, S Y; He, Y; Zheng, X; Zhao, L D; Zhao, W L; Wu, W

[Histopathological evaluation of cirrhosis reversal]

[肝硬化逆转的组织病理学评价]

Zhang, W; Sun, Y M; Chen, S Y; You, H

[Different treatment strategies in patients with HBeAg-positive and negative chronic hepatitis B]

[HBeAg阳性和阴性慢性乙型肝炎患者的不同治疗策略]

Zhang, M Y; Chen, S Y; Sun, Y M; You, H

[Clinicopathological characteristics and key therapeutic options for liver involvement with vasculitis]

【血管炎累及肝脏的临床病理特征及主要治疗方案】

Chen, S Y; Zhao, X Y

[Three cases of hemodiafiltration for the treatment of CAR-T related grade 3 - 4 cytokine release syndrome after ineffective treatment with IL-6 receptor inhibitors]

【三例 CAR-T 相关 3-4 级细胞因子释放综合征,IL-6 受体抑制剂治疗无效后行血液透析滤过治疗的病例报告】

Chen, S Y; Chen, W H; Wan, X C; Du, X; Luo, C R; Li, X Q; Zhang, X H